st7 general paediatrics
play

ST7 General Paediatrics RHSC Edinburgh Guideline overview What are - PowerPoint PPT Presentation

David Beattie ST7 General Paediatrics RHSC Edinburgh Guideline overview What are we auditing? Results What can we take from this? Questions/ discussion Dr Lizzie Bayman proposed guideline to be used locally To


  1. David Beattie ST7 General Paediatrics RHSC Edinburgh

  2.  Guideline overview  What are we auditing?  Results  What can we take from this?  Questions/ discussion

  3.  Dr Lizzie Bayman – proposed guideline to be used locally  To guide identification and assessment of short stature ◦ Primary care and general paediatrics ◦ Tertiary paediatric endocrinologists considering start of GH therapy  When to refer to tertiary services for short stature ◦ If meet any of 5 criteria  Framework of preliminary investigations for short stature

  4.  Severe short stature – height <0.4 th centile  Height 2 centiles or more below mid-parental height  Height below 2 nd centile and a height velocity over 1 year less than 25 th centile  2 years of age or more and crossing more than 1 height centile in a year  In absence of short stature, a height velocity less than 3 rd centile over 1 year or less than 10 th centile sustained over 2 years

  5.  FBC  U and E  LFT  Ferritin  Vitamin D  Coeliac screen  IGF-1  Karyotype  Bone age x-ray  If pubertal age/ signs of puberty: LH, FSH Females - Oestradiol Males - Testosterone

  6.  Aim – To establish what our currently practice is and whether children requiring growth hormone would be picked up using this proposed new guideline  Method ◦ Retrospective analysis of 25 insulin tolerance tests (ITT) performed in NHS Lothian  Lothian – in context of blood glucose <2.2 or 50% reduction from baseline: Peak GH >5ug/L: pass ITT  Peak GH 2-5ug/L: growth hormone deficiency  Peak GH <2ug/L: severe growth hormone deficiency  ◦ Height, height velocity and MPH were calculated and compared against guideline criteria of when to refer ◦ Which investigations had been performed prior to ITT

  7.  25 ITT ◦ 17 male ◦ 8 female ◦ 2 excluded as not GH naive  Data from 23 patients analysed ◦ NHS Lothian n= 20 ◦ NHS Fife n = 1 ◦ NHS Tayside n = 1 ◦ NHS Highland n = 1 ◦ NHS D&G n = 2

  8. 4 3 2 1 0 Number of criteria

  9. HV <10th centile for 2 years/ <3rd centile for 1 year >2 years of age and crossing >1 height centile in 1 year <2nd centile and HV (1 year) <25th centile >2 centiles below MPH <0.4th centile 0 2 4 6 8 10 12 14 16 Number of patients

  10. 4 3 2 1 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Height<0.4th centile >2 centiles below MPH Height <2nd centile + HV (1 year) <25th centile >2 years of age and crossing >1 height centile in 1 year HV 10th centile for 2 years/ <3rd centile for over 1 year (in absence of short stature)

  11. 4 3 2 1 0 1 2 3 4 5 6 7 8 Height<0.4th centile >2 centiles below MPH Height <2nd centile + HV (1 year) <25th centile

  12. 6 5 4 3 2 1 0 >+2 SD +1+2 SD 0+1 SD 0-1 SD -1-2 SD >-2 SD Passed ITT Failed ITT

  13. 20 15 10 5 0

  14.  Results suggests that children who had ITT and needed GH would have been picked up using this guideline ◦ All 15 needing growth hormone met at least 1 criteria ◦ 11 of 15 had only 1 criteria suggesting the differing criteria are worthwhile  0 patients met “crossing >1 height centile in 1 year”  Baseline investigations already being done (Vitamin D, coeliac, ferritin and karyotype less regular)  Difficulty in availability of karyotype results

  15.  Retrospective audit: Extract data from CAS on last 50 referrals for short stature/ slow growth against same criteria/ investigations  Prospective audit using guideline: primary care/ general paediatric clinic referrals to tertiary endocrine services for short stature

  16.  Lizzie Bayman  Jennifer Roach  Mike Crane  Louise Bath  Clare Webster  Anthony Tasker  Stuart Henderson  Raj Shyam

  17. Any questions?

Recommend


More recommend